STOCKWATCH
·
Pharmaceuticals
Monthly Update29 Jul 2025, 01:32 pm

Anuh Pharma Ltd Reports Global Growth with 3.3 MW Solar Plant and Annual Report for FY 2024-25

AI Summary

Anuh Pharma Ltd, a leading company in the pharmaceutical sector, has reported a significant growth in its financial performance for the year ended March 31, 2025. The company's total revenue for the FY 2024-25 stood at INR 65,910 Lakhs, representing a robust increase from the previous year. The company's earnings before interest, tax, depreciation, and amortization (EBITDA) also witnessed a substantial growth, reaching INR 8,725 Lakhs for the FY 2024-25. Furthermore, Anuh Pharma Ltd has setup a Solar Plant generating 3.3 MW energy, catering to about 50% of the company's energy consumption. The company's Annual Report for the FY 2024-25 has been uploaded on the stock exchange and the company's website.

Key Highlights

  • Anuh Pharma Ltd reports a total revenue of INR 65,910 Lakhs for the FY 2024-25
  • The company's EBITDA for the FY 2024-25 stands at INR 8,725 Lakhs
  • Anuh Pharma Ltd sets up a Solar Plant generating 3.3 MW energy
  • The Solar Plant caters to about 50% of the company's energy consumption
  • The company's Annual Report for the FY 2024-25 is uploaded on the stock exchange and the company's website
ANUHPHR
Pharmaceuticals
ANUH PHARMA LTD.

Price Impact